Sidebar Ads

Wednesday, September 5, 2018

Here's Why Keryx Biopharmaceuticals Dropped 19.6% in August


Here's Why Keryx Biopharmaceuticals Dropped 19.6% in August



The pharma company announced second-quarter 2018 earnings.

Related Posts:

0 comments:

Post a Comment

23andMe users struggle to delete their highly sensitive data

Multiple users said they had problems after the DNA-testing firm filed for bankruptcy protection. from BBC News https://ift.tt/1IUshML